Home › Chronic Pain › NCT06336447
VR and Cooled Genicular Nerve Radio Frequency Ablation for Chronic Knee Pain
Can Virtual Reality Improve Patient Tolerance in Patients Undergoing Water Cooled Genicular Nerve Radio Frequency Ablation in Patients With Chronic Knee Pain? A Randomized Controlled Trial
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients undergoing genicular RFA will be eligible for inclusion in the study * Patients with knee pain, baseline average of \> 4/10 * X-ray evidence of osteoarthritis of the knee * Pain duration of \>6 weeks and no previous knee surgeries * Patients will also only be included who have never undergone a RFA on the affected knee Exclusion Criteria: * Individuals who do not have evidence of osteoarthritis on X-ray, * Secondary gain expected to influence treatment outcomes * Poorly controlled psychiatric condition that could affect outcome (e.g. active substance abuse) or impose a barrier to participation * Chronic opioid use and anticoagulation therapy that cannot be stopped and could warrant a different treatment approach (e.g. phenol ablation) * Severe motion sickness * Seizure disorder * Vision loss * Pregnant * Nursing
About the study
This study will examine the impact of virtual reality used in conjunction with sedation compared to sedation alone in patients undergoing watervcooled genicular nerve ablations for chronic knee pain.
The goals of the study is to determine the relative efficacy of virtual reality as a distraction modality when used as an adjuvant to procedural sedation compared to sedation alone for procedure related pain. To assess procedural satisfaction, and 1-month pain and functional outcomes.To explore whether virtual reality and lower procedure-related pain scores affect 1-month outcomes. And finally to determine whether demographic and clinical characteristics are associated with outcome measures.
What is being tested
- Experimental: Group #1: Virtual Reality Headset (other)
- Group 2 No Virtual Reality Headset (other)
Sponsor: Northwestern University · Participants: 62 · Started: Jan 12, 2024
Contact the study team
- Paul Fitzgerald, RN,BSN,MS · Phone: 312-695-1064
Official record on ClinicalTrials.gov — NCT06336447
Locations in the U.S.
| Illinois | Northwestern Medicine Pain Center, Chicago |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.